Medicine & Health
Interleukin-12 – a messenger molecule of immune cells – was long considered to trigger the development of psoriasis. Now, researchers at the University of Zurich have shown that interleukin-12 does not actually cause the skin disease but protects against it. This also explains why common psoriasis drugs that block the messenger show insufficient treatment efficacy.
- Science Immunology
A new study led by University of California, Irvine researchers is the first to reveal the specific molecular mechanism that controls the transition from acute to chronic pain, and identifies this mechanism as a critical target for disease-modifying medicines.
- Science Advances
A new, retrospective study of medical and insurance records indicates health care costs for people with a rare disease have been underestimated and are three to five times greater than the costs for people without a rare disease. The study, led by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS), provides new evidence of the potential impact of rare diseases on public health, suggesting that nationwide medical costs for individuals with rare diseases are on par with those for cancer and heart failure. The study’s results were published Oct. 21 in the Orphanet Journal of Rare Diseases.
- Orphanet Journal of Rare Diseases
- NIH/National Center for Advancing Translational Sciences (NCATS)
COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published on October 22nd, 2021 in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.
Burt’s Bees, a pioneer in natural skin care, today announced its latest research findings on the benefits of nature-based ingredients, including bakuchiol, aloe and rice milk, to improve and restore skin health across various skin priorities, types and tones. The studies will be presented at the in-person and virtual Integrative Dermatology Symposium (IDS) from October 22 – October 24, 2021.
- Integrative Dermatology Symposium
Scientists at the UNC School of Medicine have reported in the journal JCI Insight encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.
- JCI Insight